{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:48:21Z","timestamp":1791856101811,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.contraception.2012.09.024","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T05:45:28Z","timestamp":1351662328000},"page":"773-781","source":"Crossref","is-referenced-by-count":15,"title":["Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250-mcg norgestimate and 35-mcg ethinyl estradiol"],"prefix":"10.1016","volume":"87","author":[{"given":"Sigrid","family":"Nyberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.09.024_bb0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(01)00218-9","article-title":"A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation","volume":"64","author":"Sanders","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.024_bb0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.09.024_bb0015","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2006.05.012","article-title":"Oral contraceptives and premenstrual symptoms: comparison of a 21\/7 and extended regimen","volume":"195","author":"Coffee","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.09.024_bb0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(92)90006-F","article-title":"Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations","volume":"46","author":"B\u00e4ckstr\u00f6m","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.024_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-0327(90)90126-S","article-title":"Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder","volume":"20","author":"Pearlstein","year":"1990","journal-title":"J Affect Disord"},{"key":"10.1016\/j.contraception.2012.09.024_bb0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0165-0327(01)00356-1","article-title":"To what extent do oral contraceptives influence mood and affect?","volume":"70","author":"Oinonen","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.contraception.2012.09.024_bb0035","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0002-9378(03)00927-X","article-title":"Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration","volume":"189","author":"Joffe","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.09.024_bb0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/00016348809004191","article-title":"Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo","volume":"67","author":"Hammarb\u00e4ck","year":"1988","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.09.024_bb0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200317050-00003","article-title":"The role of hormones and hormonal treatments in premenstrual syndrome","volume":"17","author":"B\u00e4ckstr\u00f6m","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.contraception.2012.09.024_bb0050","doi-asserted-by":"crossref","first-page":"139.e1","DOI":"10.1016\/j.ajog.2009.03.016","article-title":"Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder","volume":"201","author":"Segebladh","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.09.024_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199801223380401","article-title":"Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome","volume":"338","author":"Schmidt","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2012.09.024_bb0060","first-page":"1","article-title":"Mood changes and menstrual symptoms with different gestagen\/estrogen combinations. A double-blind comparison with a placebo","volume":"236","author":"Cullberg","year":"1972","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.contraception.2012.09.024_bb0065","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1067\/mob.2000.107781","article-title":"Negative mood changes during hormone replacement therapy: a comparison between two progestogens","volume":"183","author":"Bj\u00f6rn","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.09.024_bb0070","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1210\/jc.2002-020755","article-title":"Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy","volume":"88","author":"Bj\u00f6rn","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.09.024_bb0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00005053-197209000-00002","article-title":"History of depression as a risk factor for depression with oral contraceptives and discontinuance","volume":"155","author":"Kutner","year":"1972","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.contraception.2012.09.024_bb0080","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pbb.2006.06.008","article-title":"Oral contraceptives and neuroactive steroids","volume":"84","author":"Rapkin","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.contraception.2012.09.024_bb0085","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.contraception.2012.09.024_bb0090","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.1994.03520220043029","article-title":"Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study","volume":"272","author":"Spitzer","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2012.09.024_bb0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/01674828909016676","article-title":"Diagnosis of premenstrual tension syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis","volume":"10","author":"Hammarb\u00e4ck","year":"1989","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.09.024_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00737-010-0201-3","article-title":"Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus","volume":"14","author":"O\u00b4Brien","year":"2011","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.contraception.2012.09.024_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2012.09.024_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-3999(92)90090-O","article-title":"A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive","volume":"36","author":"Graham","year":"1992","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.contraception.2012.09.024_bb0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2007.04.002","article-title":"The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol","volume":"76","author":"Greco","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.024_bb0120","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0306-4530(90)90072-H","article-title":"Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS)","volume":"15","author":"Dhar","year":"1990","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.contraception.2012.09.024_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01674828709019585","article-title":"The effects of oral contraceptives on mood and sexuality: a comparison of triphasic and combined preparations","volume":"7","author":"Bancroft","year":"1987","journal-title":"J Psychosom Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.09.024_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.contraception.2011.05.008","article-title":"Continuous oral levonorgestrel\/ethinyl estradiol for treating premenstrual dysphoric disorder","volume":"85","author":"Halbreich","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.024_bb0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00042192-200201000-00003","article-title":"Progestogens in hormonal replacement therapy: new molecules, risks, and benefits","volume":"9","author":"Sitruk-Ware","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.contraception.2012.09.024_bb0140","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/713604447","article-title":"Use of an oral contraceptive containing drospirenone in an extended regimen","volume":"8","author":"Sillem","year":"2003","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.09.024_bb0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00404-006-0280-6","article-title":"Efficacy of Yasmin in premenstrual symptoms","volume":"275","author":"Taneepanichskul","year":"2007","journal-title":"Arch Gynecol Obstet"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2012.09.024_bb0150","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2012.09.024_bb0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.024_bb0160","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00016349509021201","article-title":"Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study","volume":"74","author":"Wang","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.09.024_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2004.07.010","article-title":"A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms","volume":"71","author":"Sangthawan","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.024_bb0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.024_bb0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.contraception.2012.09.024_bb0180","first-page":"CD006586","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","volume":"2","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.09.024_bb0185","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal","volume":"68","author":"Stanczyk","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2012.09.024_bb0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09513590009167685","article-title":"Inhibition of scin 5 alpha-reductase by oral contraceptive progestins in vitro","volume":"14","author":"Rabe","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2012.09.024_bb0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0010-7824(02)00473-0","article-title":"Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties","volume":"67","author":"Hammond","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.024_bb0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0306-4530(92)90058-F","article-title":"Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls","volume":"17","author":"Eriksson","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.contraception.2012.09.024_bb0205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0010-7824(01)00179-2","article-title":"Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol","volume":"63","author":"Boyd","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.09.024_bb0210","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1196\/annals.1286.005","article-title":"Pathogenesis in menstrual cycle-linked CNS disorders","volume":"1007","author":"B\u00e4ckstr\u00f6m","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.contraception.2012.09.024_bb0215","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1210\/er.2006-0050","article-title":"Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system","volume":"28","author":"Schumacher","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2012.09.024_bb0220","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuroscience.2011.03.061","article-title":"Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons","volume":"191","author":"B\u00e4ckstr\u00f6m","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.contraception.2012.09.024_bb0225","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.fertnstert.2005.10.031","article-title":"Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes","volume":"85","author":"Rapkin","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.09.024_bb0230","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/09513590701253511","article-title":"Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome","volume":"23","author":"Nyberg","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2012.09.024_bb0235","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00004714-200210000-00013","article-title":"Allopregnanolone levels and symptom improvement in severe premenstrual syndrome","volume":"22","author":"Freeman","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.contraception.2012.09.024_bb0240","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0006-3223(00)01044-1","article-title":"Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder","volume":"49","author":"Girdler","year":"2001","journal-title":"Biol Psychiatry"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412008724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412008724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T13:25:57Z","timestamp":1542633957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412008724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0010782412008724"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.09.024","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}